<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Case Study: Wearable Pulse Oximeter | Ian Chan</title>
    <link rel="stylesheet" href="styles.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Lora:wght@400;700&family=Montserrat:wght@400;700&display=swap" rel="stylesheet">
</head>
<body>

    <header class="project-header">
        <div class="wrapper">
            <h1>Investment Thesis: Wearable Pulse Oximeter</h1>
            <p>An award-winning remote patient monitoring device.</p>
        </div>
    </header>

    <main class="project-content">
        <div class="wrapper">
            <h3>Executive Summary</h3>
            <p>This document outlines the investment case for a novel wearable pulse oximeter designed to address a critical gap in the remote patient monitoring (RPM) market. By combining user-centric design with robust data collection, the device offers a superior solution for continuous health tracking, validated by a Top Design Award recognizing its significant commercial and investment potential.</p>

            <h3>The Market Opportunity</h3>
            <p>The global remote patient monitoring market is experiencing explosive growth, driven by an aging population, the rising prevalence of chronic diseases, and a post-pandemic shift towards telehealth. Despite a crowded market, a significant gap exists for devices that are both medically accurate and seamlessly integrated into a user's daily life. Existing solutions are often cumbersome, leading to low patient compliance and inconsistent data—a major pain point for clinicians and healthcare providers who rely on this data for treatment decisions.</p>

            <h3>The Unique Solution (The Product)</h3>
            <p>Our team led the end-to-end development of a wearable pulse oximeter that directly addresses these shortcomings. The device features a discreet, ergonomic form factor designed for long-term wear without discomfort. Its core technical innovation lies in an advanced sensor array and proprietary algorithm that ensures high-fidelity SpO2 and heart rate readings, even during periods of low perfusion or motion. This technical advantage creates a significant competitive moat by providing more reliable and actionable data than competing products.</p>

            <h3>Go-to-Market & Commercial Viability</h3>
            <p>A comprehensive business case and market viability analysis was authored and presented to a panel of industry experts. The proposed business model focuses on a B2B2C strategy, partnering with healthcare systems and telehealth providers who can deploy the device to their patient populations. This approach leverages existing distribution channels and aligns with the industry's move towards value-based care, where reliable remote monitoring is key to reducing hospital readmissions and managing chronic conditions effectively.</p>

            <h3>Validation & Investment Potential</h3>
            <p>The project's investment potential was externally validated when it secured the Top Design Award. The judging criteria heavily weighted commercial viability, market fit, and the strength of the business case. This award serves as a powerful third-party endorsement of the project's strategic direction and its potential to capture significant market share.</p>

            <a href="index.html#theses" class="back-link">← Back to Investment Theses</a>
        </div>
    </main>

    <footer class="site-footer">
        <div class="wrapper">
            <p>&copy; 2025 Ian H.Y. Chan. All Rights Reserved.</p>
        </div>
    </footer>

</body>
</html>